Methods for integration of pharmacokinetic and phenotypic information in the treatment of infection with human immunodeficiency virus

被引：16

作者：

Acosta, EP ^{[1
]}

King, JR ^{[1
]}

机构：

[1] Univ Alabama Birmingham, Div Clin Pharmacol, Birmingham, AL 35294 USA

来源：

CLINICAL INFECTIOUS DISEASES | 2003年 / 36卷 / 03期

关键词：

D O I：

10.1086/345993

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Interest in monitoring antiretroviral drug concentrations in human immunodeficiency virus-infected patients has gained considerable momentum in recent years. We present a potential method for integrating pharmacokinetic and phenotypic information that will assist clinicians in choosing optimal treatment regimens for their patients and that will provide an approach for the interpretation of antiretroviral plasma drug concentrations.

引用

页码：373 / 377

页数：5

共 18 条

[1] Pharmacodynamics of human immunodeficiency virus type 1 protease inhibitors [J].

Acosta, EP ;

Kakuda, TN ;

Brundage, RC ;

Anderson, PL ;

Fletcher, CV .

CLINICAL INFECTIOUS DISEASES, 2000, 30 :S151-S159

[2] Position paper on therapeutic drug monitoring of antiretroviral agents [J].

Acosta, EP ;

Gerber, JG .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 2002, 18 (12) :825-834

[3]

BERTZ R, 2001, 2 INT WORKSH CLIN PH

[4] A retrospective, cohort-based survey of patients using twice-daily indinavir plus ritonavir combinations: Pharmacokinetics, safety, and efficacy [J].

Burger, DM ;

Hugen, PWH ;

Aarnoutse, RE ;

Dieleman, JP ;

Prins, JM ;

van der Poll, T ;

ten Veen, JH ;

Mulder, JW ;

Meenhorst, PL ;

Blok, WL ;

van der Meer, JTM ;

Reiss, P ;

Lange, JMA .

JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 26 (03) :218-224

[5]

Cardiello PG, 2002, J ACQ IMMUN DEF SYND, V29, P464, DOI 10.1097/00042560-200204150-00006

[6] Drug resistance and predicted virologic responses to human immunodeficiency virus type 1 protease inhibitor therapy [J].

Condra, JH ;

Petropoulos, CJ ;

Ziermann, R ;

Schleif, WA ;

Shivaprakash, M ;

Emini, EA .

JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (03) :758-765

[7]

D'Argenio DZ, 1997, ADAPT 2 USERS GUIDE

[8]

GARRAFFO R, 2001, 41 INT C ANT AG CHEM, P14

[9]

GERBER JG, 2002, 14 INT AIDS C BARC S

[10]

HSU A, 2001, 8 C RETR OPP INF CHI, P143

← 1 2 →